• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[孤立性心肌致密化不全,特别强调心律失常并发症]

[Isolated noncompaction cardiomyopathy with special emphasis on arrhythmia complications].

作者信息

Gerecke B, Engberding R

机构信息

I. Medizinische Klinik, Klinikum Wolfsburg, Sauerbruchstraße 7, 38440, Wolfsburg, Germany.

出版信息

Herzschrittmacherther Elektrophysiol. 2012 Sep;23(3):201-10. doi: 10.1007/s00399-012-0226-6. Epub 2012 Sep 25.

DOI:10.1007/s00399-012-0226-6
PMID:23008085
Abstract

Isolated noncompaction cardiomyopathy (NCCM) is a rare genetically determined myocardial disease caused by abnormal fetal development of the myocardium resulting in a thin compacted and a thicker noncompacted layer of the affected left ventricular (LV) wall. The genetic basis of NCCM is heterogenous. Diagnosis can be made using echocardiography or magnetic resonance imaging. The diagnostic criteria for NCCM are still under discussion. Afflicted patients may present with various symptoms caused by arrhythmias, heart failure and cardioembolic events. Severely reduced LV function as well as left bundle branch block and atrial fibrillation were shown to be linked to worse outcomes. Treatment in patients with NCCM should be targeted at individual symptoms and clinical findings. Therapy includes pharmacological treatment, and in individual cases ablation or device therapy, as well as consideration for heart transplantation in selected cases. Aside from regular clinical follow-up of patients with NCCM screening of first degree family members with assessment of medical history, physical examination, ECG recording, and echocardiography are recommended.

摘要

孤立性心肌致密化不全(NCCM)是一种罕见的遗传性心肌病,由心肌胎儿发育异常引起,导致受累左心室(LV)壁的致密层变薄,非致密层增厚。NCCM的遗传基础是异质性的。可使用超声心动图或磁共振成像进行诊断。NCCM的诊断标准仍在讨论中。患病患者可能会出现由心律失常、心力衰竭和心脏栓塞事件引起的各种症状。左心室功能严重降低以及左束支传导阻滞和心房颤动与较差的预后有关。NCCM患者的治疗应针对个体症状和临床发现。治疗包括药物治疗,个别情况下进行消融或器械治疗,以及在特定病例中考虑心脏移植。除了对NCCM患者进行定期临床随访外,建议对一级家庭成员进行筛查,评估病史、体格检查、心电图记录和超声心动图。

相似文献

1
[Isolated noncompaction cardiomyopathy with special emphasis on arrhythmia complications].[孤立性心肌致密化不全,特别强调心律失常并发症]
Herzschrittmacherther Elektrophysiol. 2012 Sep;23(3):201-10. doi: 10.1007/s00399-012-0226-6. Epub 2012 Sep 25.
2
Thickness and Ratio of Noncompacted and Compacted Layers of the Left Ventricular Myocardium Evaluated in 56 Normal Fetuses by Two-Dimensional Echocardiography.二维超声心动图评价 56 例正常胎儿左心室心肌的非致密层和致密层厚度及厚度比。
Biomed Res Int. 2019 Jan 23;2019:3726846. doi: 10.1155/2019/3726846. eCollection 2019.
3
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy.非致密性心肌病的抗凝治疗策略。
ESC Heart Fail. 2022 Feb;9(1):241-250. doi: 10.1002/ehf2.13694. Epub 2021 Dec 16.
4
Noncompaction cardiomyopathy in the State of Qatar.卡塔尔国的致密化不全型心肌病。
Saudi Med J. 2007 Mar;28(3):429-34.
5
[Noncompaction cardiomyopathy].[致密化不全心肌病]
Herz. 2015 Jun;40(4):583-90. doi: 10.1007/s00059-015-4233-3.
6
Cardiac Phenotypes, Genetics, and Risks in Familial Noncompaction Cardiomyopathy.家族性心肌致密化不全症的心脏表型、遗传学和风险。
J Am Coll Cardiol. 2019 Apr 9;73(13):1601-1611. doi: 10.1016/j.jacc.2018.12.085.
7
State-of-the art review: Noncompaction cardiomyopathy in pediatric patients.最新综述:小儿非致密性心肌病。
Heart Fail Rev. 2022 Jan;27(1):15-28. doi: 10.1007/s10741-021-10089-7. Epub 2021 Mar 14.
8
No relationship between left ventricular radial wall motion and longitudinal velocity and the extent and severity of noncompaction cardiomyopathy.左心室径向壁运动与纵向速度和致密化不全型心肌病的范围及严重程度之间无相关性。
Cardiovasc Ultrasound. 2012 Mar 19;10:9. doi: 10.1186/1476-7120-10-9.
9
Left ventricular strain reduction is not confined to the noncompacted segments in noncompaction cardiomyopathy-insights from the three-dimensional speckle tracking echocardiographic MAGYAR-path study.左心室应变降低并不局限于心肌致密化不全心肌病的非致密化节段——来自三维斑点追踪超声心动图MAGYAR-path研究的见解
Echocardiography. 2014 May;31(5):638-43. doi: 10.1111/echo.12447. Epub 2013 Nov 26.
10
Diagnostic Cardiovascular Magnetic Resonance Imaging Criteria in Noncompaction Cardiomyopathy and the Yield of Genetic Testing.非致密性心肌病的诊断心血管磁共振成像标准和基因检测的结果。
Can J Cardiol. 2021 Mar;37(3):433-442. doi: 10.1016/j.cjca.2020.05.021. Epub 2020 May 21.

引用本文的文献

1
Noncompaction Cardiomyopathy-History and Current Knowledge for Clinical Practice.非致密型心肌病——临床实践的历史与当前认知
J Clin Med. 2021 Jun 1;10(11):2457. doi: 10.3390/jcm10112457.

本文引用的文献

1
Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis.成人的小梁化(非致密化)心肌和致密化心肌:动脉粥样硬化的多民族研究。
Circ Cardiovasc Imaging. 2012 May 1;5(3):357-66. doi: 10.1161/CIRCIMAGING.111.971713. Epub 2012 Apr 12.
2
Diagnostic value of rigid body rotation in noncompaction cardiomyopathy.刚体旋转在心肌致密化不全中的诊断价值。
J Am Soc Echocardiogr. 2011 May;24(5):548-55. doi: 10.1016/j.echo.2011.01.002. Epub 2011 Feb 22.
3
Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy.
非致密性心肌病患者植入式心脏复律除颤器一级和二级预防的适应证和结局。
J Cardiovasc Electrophysiol. 2011 Aug;22(8):898-904. doi: 10.1111/j.1540-8167.2011.02015.x. Epub 2011 Feb 18.
4
Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?左心室心肌致密化不全的再认识:一种具有遗传异质性的独特表型?
Eur Heart J. 2011 Jun;32(12):1446-56. doi: 10.1093/eurheartj/ehq508. Epub 2011 Jan 31.
5
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction.心脏再同步治疗对孤立性心室非致密化心肌病的影响。
Heart. 2011 Feb;97(4):295-300. doi: 10.1136/hrt.2010.211607. Epub 2010 Dec 16.
6
Left ventricular noncompaction: a new form of heart failure.左心室心肌致密化不全:一种新型心力衰竭。
Heart Fail Clin. 2010 Oct;6(4):453-69, viii. doi: 10.1016/j.hfc.2010.06.005.
7
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.2010年欧洲心脏病学会心力衰竭器械治疗指南重点更新:2008年欧洲心脏病学会急慢性心力衰竭诊断和治疗指南及2007年欧洲心脏病学会心脏再同步化治疗指南的更新。由心力衰竭协会和欧洲心律协会特别贡献制定。
Eur Heart J. 2010 Nov;31(21):2677-87. doi: 10.1093/eurheartj/ehq337. Epub 2010 Aug 27.
8
Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompaction.植入式心脏复律除颤器和心脏再同步治疗左心室致密化不全。
Heart Rhythm. 2010 Nov;7(11):1545-9. doi: 10.1016/j.hrthm.2010.05.025. Epub 2010 May 21.
9
Isolated non-compaction cardiomyopathy.孤立性非致密性心肌病。
Dtsch Arztebl Int. 2010 Mar;107(12):206-13. doi: 10.3238/arztebl.2010.0206. Epub 2010 Mar 26.
10
Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.家族性心肌病的分子诊断学进展:一切的核心。
Expert Rev Mol Diagn. 2010 Apr;10(3):329-51. doi: 10.1586/erm.10.13.